Areté
← All peptides
Master antioxidant tripeptidecommunity

Glutathione

Glutathione (GSH)

The body’s “master antioxidant” — and a genuine taxonomy edge case. Glutathione is a tripeptide (glutamate–cysteine–glycine), so it technically belongs on a peptide wiki, but nobody runs it as a peptide: functionally it’s an antioxidant and enzyme cofactor your cells already make in millimolar amounts. The community reaches for it for “detox” and antioxidant support — and, far more loudly in some markets, for skin lightening. The honest read is that the marquee uses are the weakly-evidenced ones.

Type
Tripeptide
Area
Vitamins & cofactors
Class
Master antioxidant tripeptide
Standard dose
250–500 mg/day is the common range, but oral bioavailability is poor — the tripeptide is largely broken down before absorption, so this is the weakest route on paper
Evidence
community

What it is

Inside the cell it’s the workhorse of redox defense — it neutralizes free radicals and serves as the cofactor that lets the body’s detox enzymes do their job. That’s the real biology. What people actually buy it for is different: antioxidant/anti-aging and liver “detox” support, and — the headline use in much of Asia and increasingly elsewhere — skin lightening (a brighter, more even, lighter complexion). It’s run IV, SubQ, nebulized/inhaled, or oral, depending on which claim someone is chasing.

The interesting tension is that this is one of the most important molecules in human biochemistry and one of the worst-delivered supplements. Endogenous GSH is everywhere and essential; the swallowed version is mostly torn apart in the gut before it ever reaches the blood, which is why the community is obsessed with routes that bypass digestion — IV, injection, nebulizer, even sublingual. The skin-lightening effect, where it’s real, works the opposite way from a tan: it’s thought to nudge melanin production from darker eumelanin toward lighter pheomelanin, so it lightens rather than bleaches. That cosmetic use is also where the genuinely scary safety reports live.

Mechanism

GSH is a redox buffer: its cysteine thiol gets oxidized to neutralize reactive oxygen species, then recycled back by glutathione reductase, and it acts as the obligatory cofactor for glutathione peroxidases and glutathione-S-transferases that clear peroxides and xenobiotics. The skin-lightening rationale piggybacks on that chemistry — glutathione is proposed to inhibit tyrosinase (the rate-limiting enzyme in melanin synthesis) and to shift melanogenesis toward lighter pigment. The “detox” and anti-aging claims extrapolate from the same antioxidant role to whole-body benefit, which is exactly where the evidence stops keeping up.

Standard dose

Oral250–500 mg/day is the common range, but oral bioavailability is poor — the tripeptide is largely broken down before absorption, so this is the weakest route on paper (proposed — pending dosing review)community
Skin-lightening (reported)IV protocols in the literature cluster around ~600 mg–1.2 g once or twice weekly — this is the unapproved use tied to the serious safety reports belowcommunity
Other routesSubQ injection and nebulized/inhaled use are run to bypass the gut; sublingual/liposomal forms are marketed for the same reasoncommunity
Cofactor stackOften paired with vitamin C, alpha-lipoic acid, and NAC (a cysteine precursor) — the supporting-cast nutrients that regenerate or supply GSHcommunity
Pushing higher— going beyond the standard dosecommunity
This is a compound where escalating the dose mostly escalates the risk, not the proven benefit. The high-dose, high-frequency IV protocols are precisely the ones regulators have flagged for fatal skin reactions, and pushing oral higher runs into the bioavailability wall — more swallowed glutathione doesn’t reliably mean more in your blood. The honest framing the better sources land on: the well-supported facts are about endogenous glutathione’s biology, not about megadosing exogenous GSH, and the most aggressive route (IV skin-lightening) is the least defensible.

Side effects & cautions

Oral and inhaled use is generally reported as well tolerated in the short term. The serious signal is concentrated in IV skin-lightening: regulators (notably the Philippine FDA) have reported rare but potentially fatal severe cutaneous reactions — Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) — along with thyroid and kidney dysfunction, and infection/air-embolism risk from unsterile or improper IV technique. There are documented case reports of SJS/TEN following both IV and oral whitening products. Layered on top is the usual unregulated-sourcing problem: counterfeit and contaminated vials are common in the gray market, and IV administration multiplies the consequences of a bad vial.

Stacking

It’s less a peptide-stack compound than a node in an antioxidant-support routine. The most consistent pairings are its biochemical relatives: NAC (supplies cysteine, the rate-limiting building block), vitamin C, and alpha-lipoic acid, which help maintain or recycle glutathione and are frequently co-formulated in the oral skin-lightening products studied. There’s no established peptide-to-peptide protocol — when people “stack” glutathione they mean these cofactors, not other compounds on this wiki.

Evidence & sources

The biology of endogenous glutathione is rock-solid; the supplement uses are not. Skin-lightening has the most human data — small randomized trials (oral and IV/topical) show modest, often statistically borderline lightening, while the IV route is unapproved and carries the serious-reaction reports. A randomized IV trial in Parkinson’s found it safe but no better than placebo on motor scores. Oral bioavailability is poor, and the broad “detox”/anti-aging claims have essentially no controlled human support.

  • Aquilano K, Baldelli S, Ciriolo MR (2014)Review
    Glutathione: new roles in redox signaling for an old antioxidant
    Frontiers in Pharmacology — review of GSH biologyPMID 25206336
  • Arjinpathana N, Asawanonda P (2012)Human RCT
    Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study
    J Dermatolog Treat — 60 subjects, oral 500 mg/dayPMID 20524875
  • Hauser RA et al. (2009)Human RCT
    Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson’s disease
    Movement Disorders — IV 1,400 mg, 3×/weekPMID 19230029
  • Johnson JS et al. (2025)Human study
    Intravenous glutathione and vitamin supplementation causing Stevens-Johnson syndrome: a case report
    J Burn Care Res — severe cutaneous reactionDOI 10.1093/jbcr/iraf027
  • Sonthalia S, Daulatabad D, Sarkar R (2016)Review
    Glutathione as a skin whitening agent: facts, myths, evidence and controversies
    Indian J Dermatol Venereol Leprol — reviewPMID 27088927

More in Vitamins & cofactors